about
The BRCA2-interacting protein BCCIP functions in RAD51 and BRCA2 focus formation and homologous recombinational repairGenomic structure of the human BCCIP gene and its expression in cancerAssociation of human RAD52 protein with transcription factorsBCCIP functions through p53 to regulate the expression of p21Waf1/Cip1A mechanism for synergy with combined mTOR and PI3 kinase inhibitors.GSI-I (Z-LLNle-CHO) inhibits γ-secretase and the proteosome to trigger cell death in precursor-B acute lymphoblastic leukemia.Genetic Deficiency of Mtdh Gene in Mice Causes Male Infertility via Impaired Spermatogenesis and Alterations in the Expression of Small Non-coding RNAs.Cytoplasmic Metadherin (MTDH) provides survival advantage under conditions of stress by acting as RNA-binding protein.BCCIP regulates homologous recombination by distinct domains and suppresses spontaneous DNA damage.Roles of BCCIP in chromosome stability and cytokinesis.Strategies for Molecularly Enhanced Chemotherapy to Achieve Synthetic Lethality in Endometrial Tumors with Mutant p53Comprehensive profiling of EGFR/HER receptors for personalized treatment of gynecologic cancers.Role of metadherin in estrogen-regulated gene expression.IKK inhibitor bay 11-7082 induces necroptotic cell death in precursor-B acute lymphoblastic leukaemic blasts.Differential expression of Ikaros isoforms in monozygotic twins with MLL-rearranged precursor-B acute lymphoblastic leukemia.Synthetically lethal nanoparticles for treatment of endometrial cancer.AZD1775 Increases Sensitivity to Olaparib and Gemcitabine in Cancer Cells with p53 Mutations.Combination of Proteasome and Histone Deacetylase Inhibitors Overcomes the Impact of Gain-of-Function p53 MutationsMetadherin enhances vulnerability of cancer cells to ferroptosisMTDH/AEG-1 downregulation using pristimerin-loaded nanoparticles inhibits Fanconi anemia proteins and increases sensitivity to platinum-based chemotherapy
P50
Q24556631-E93CE6C2-4E46-4F0B-B8AE-F7ACA6D3F3B5Q28202991-4089E6A6-B3B4-40FB-BA99-74EBA3D4CFC9Q28206223-27BEDDBB-9E33-4A73-AB95-DDD6712FB6F7Q28292868-97C24A79-42D9-4425-BDCA-04BDA4F71B15Q34062367-2702B31D-6E37-423A-A9B9-C455F703F3CDQ35208033-07A67BD3-35AD-40FB-BF10-14C72667EBD6Q35583031-D3A708C7-0AF4-497D-9DE7-5A15574FA0DDQ35762980-4359E1B0-29C9-4B3A-84A8-288835CA7EADQ36328985-258F5B23-B07B-4D0B-9831-A32BD8D99D28Q37155775-2B4FD280-E186-45E7-B9EE-E184858C74C4Q37411955-002DE57E-4238-4A37-BFA9-4293A60FA40AQ37671783-C4ECE93A-B862-4524-9844-AEA5AED0F382Q38719595-67E180EB-CD51-4E06-8EA6-E032B7249577Q43230774-761C018B-C8BA-4F85-928C-08D778549851Q46170598-E1B6B64D-E8D6-4326-B562-07ED1C6B5420Q47370432-822E56B4-5F6C-40D4-8501-D8A7304FF495Q54108341-E544D864-144E-42D9-93EC-7E53E907EC9FQ60950807-DC3FEC2E-59DF-4659-937C-D5B2B124A142Q90133807-16E5CC64-B343-46B8-A38B-95169BE1E485Q93061205-1DF9E639-9D6F-4F88-93BE-18F94EAA1F16
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0002-9612-6438
@en
name
Xiangbing Meng
@ast
Xiangbing Meng
@en
Xiangbing Meng
@es
Xiangbing Meng
@nl
type
label
Xiangbing Meng
@ast
Xiangbing Meng
@en
Xiangbing Meng
@es
Xiangbing Meng
@nl
prefLabel
Xiangbing Meng
@ast
Xiangbing Meng
@en
Xiangbing Meng
@es
Xiangbing Meng
@nl
P106
P31
P496
0000-0002-9612-6438